The 2019 annual general meeting for Canadian Association of Pompe will be held by conference call on Sunday, May 26, 2019. If you haven’t received notification, please contact us here.
Recent Posts
- Nexviazyme Meets All Endpoints in Phase 3 Study for Infantile-Onset Pompe Disease
- First Participant Dosed in Phase 1/2 Gene Therapy Trial for Late-Onset Pompe Disease
- First Patients Enrolled in Phase 2 Trial of SRT for Late-Onset Pompe Disease
- Aro Biotherapeutics reports positive phase 1b results for ABX1100
- 2025 Pompe Empowerment Workshop : Vancouver
Categories
Tags
advocacy
awards
Awareness
Breakthrough therapy designation
business
CAP
chaperone
clinical trials
compassion
CORD
COVID-19
ERT
Extraordinary Measures
FDA
fundraising
gene therapy
genetics
getting treated
grants
guest blogger
Health Canada
home infusions
IND
Int'l Pompe Day
IPA
Keroul
late-onset
law
living with Pompe
meetings
Muscular Dystrophy Canada
newborn screening
NIH
Orphan Drug Framework
Orphanet
portraits
preclinical
privacy
Rare Disease
Rare Disease Day
research
respite
RQMO
substrate reduction therapy
video
